CO4980880A1 - Hidrato novedoso n-(2-piridil)amino)etoxi]etoxi]bencil]tiazolidin-2-4-diona - Google Patents
Hidrato novedoso n-(2-piridil)amino)etoxi]etoxi]bencil]tiazolidin-2-4-dionaInfo
- Publication number
- CO4980880A1 CO4980880A1 CO98074834A CO98074834A CO4980880A1 CO 4980880 A1 CO4980880 A1 CO 4980880A1 CO 98074834 A CO98074834 A CO 98074834A CO 98074834 A CO98074834 A CO 98074834A CO 4980880 A1 CO4980880 A1 CO 4980880A1
- Authority
- CO
- Colombia
- Prior art keywords
- etoxi
- provides
- amino
- hydrate
- tiazolidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1. - Un hidrato de la sal de ácido maleico de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, caracterizado porque:(i) comprende agua en el intervalo de 0,4 a 2,5% p/p; y (ii) proporciona un espectro infrarrojo que contiene picos a 1749, 1703, 1645, 1623, 1365 y 736 cm-1 ; y/o(iii) proporciona un modelo de difracción de rayos X en polvo (XRPD) sustancialmente como se presenta en la Figura II y/o(iv) proporciona un espectro Raman que contiene picos a 3106, 3O69, 3OO2, 2961, 175O, 1718, 1684, 1385, 1335, 1229, 1078, 917, 428 y 349 cm-1 y/o(v) proporciona un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos sustancialmente como los presentados en la Tabla II. Tabla IIDesplazamientos químicos de 13C del HidratoDesplazamiento químico (ppm)35,7 112,9 (2 resonancias) 136,8 173,637,9 119,7 143,0 176,650,3 129,1 153,257,0 133,2 157,465,6 134,0 168,6109,3 136,1 171,7
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726566.4A GB9726566D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4980880A1 true CO4980880A1 (es) | 2000-11-27 |
Family
ID=10823692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98074834A CO4980880A1 (es) | 1997-12-16 | 1998-12-16 | Hidrato novedoso n-(2-piridil)amino)etoxi]etoxi]bencil]tiazolidin-2-4-diona |
Country Status (35)
| Country | Link |
|---|---|
| EP (2) | EP1040110A1 (es) |
| JP (1) | JP2002508373A (es) |
| KR (1) | KR100549142B1 (es) |
| CN (3) | CN101381367A (es) |
| AP (1) | AP1365A (es) |
| AR (1) | AR017214A1 (es) |
| AU (1) | AU1967999A (es) |
| BG (1) | BG64988B1 (es) |
| BR (1) | BR9813600A (es) |
| CA (1) | CA2314107A1 (es) |
| CO (1) | CO4980880A1 (es) |
| CZ (1) | CZ299965B6 (es) |
| DZ (1) | DZ2681A1 (es) |
| EA (1) | EA004260B1 (es) |
| EG (1) | EG22337A (es) |
| GB (1) | GB9726566D0 (es) |
| HR (1) | HRP20000408B1 (es) |
| HU (1) | HUP0100509A3 (es) |
| IL (1) | IL136424A (es) |
| IN (1) | IN192487B (es) |
| MA (1) | MA26580A1 (es) |
| MY (1) | MY135612A (es) |
| NO (1) | NO317254B1 (es) |
| OA (1) | OA11766A (es) |
| PE (1) | PE20000058A1 (es) |
| PL (1) | PL341146A1 (es) |
| RS (1) | RS50126B (es) |
| SA (1) | SA99191115B1 (es) |
| SK (1) | SK286618B6 (es) |
| TR (2) | TR200001799T2 (es) |
| TW (1) | TW509690B (es) |
| UA (1) | UA72198C2 (es) |
| UY (2) | UY25304A1 (es) |
| WO (1) | WO1999031095A1 (es) |
| ZA (1) | ZA9811506B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
| KR100744359B1 (ko) * | 1999-04-23 | 2007-07-30 | 스미스클라인비이참피이엘시이 | 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도 |
| TR200103060T2 (tr) * | 1999-04-23 | 2002-05-21 | Smithkline Beecham P. L. C. | Yeni farmasötik maddeler |
| ATE246191T1 (de) * | 1999-04-23 | 2003-08-15 | Smithkline Beecham Plc | Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz |
| WO2001081327A1 (fr) | 2000-04-25 | 2001-11-01 | Kyorin Pharmaceutical Co., Ltd. | Nouveau cristal stable de derive thiazolidinedione et son procede de production |
| GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
| CA2426117A1 (en) * | 2000-09-26 | 2002-04-04 | Dr. Reddy's Research Foundation | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| WO2003050112A1 (en) * | 2001-12-13 | 2003-06-19 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
| GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0129872D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| SG47100A1 (en) * | 1994-02-10 | 1998-03-20 | Smithkline Beecham Plc | Use of insulin sensitisers for treating renal diseases |
-
1997
- 1997-12-16 GB GBGB9726566.4A patent/GB9726566D0/en not_active Ceased
-
1998
- 1998-12-14 KR KR1020007006515A patent/KR100549142B1/ko not_active IP Right Cessation
- 1998-12-14 TR TR2000/01799T patent/TR200001799T2/xx unknown
- 1998-12-14 CA CA002314107A patent/CA2314107A1/en not_active Abandoned
- 1998-12-14 MA MA25389A patent/MA26580A1/fr unknown
- 1998-12-14 CN CNA200810087031XA patent/CN101381367A/zh active Pending
- 1998-12-14 JP JP2000539019A patent/JP2002508373A/ja not_active Withdrawn
- 1998-12-14 AU AU19679/99A patent/AU1967999A/en not_active Abandoned
- 1998-12-14 IL IL13642498A patent/IL136424A/xx unknown
- 1998-12-14 CZ CZ20002204A patent/CZ299965B6/cs not_active IP Right Cessation
- 1998-12-14 OA OA1200000178A patent/OA11766A/en unknown
- 1998-12-14 RS YUP-363/00A patent/RS50126B/sr unknown
- 1998-12-14 EP EP98964510A patent/EP1040110A1/en not_active Withdrawn
- 1998-12-14 WO PCT/EP1998/008155 patent/WO1999031095A1/en active IP Right Grant
- 1998-12-14 EP EP05077331A patent/EP1661895A1/en not_active Withdrawn
- 1998-12-14 HU HU0100509A patent/HUP0100509A3/hu unknown
- 1998-12-14 PL PL98341146A patent/PL341146A1/xx not_active Application Discontinuation
- 1998-12-14 SK SK917-2000A patent/SK286618B6/sk not_active IP Right Cessation
- 1998-12-14 CN CN98812089A patent/CN1281453A/zh active Pending
- 1998-12-14 CN CNA2008100870305A patent/CN101302215A/zh active Pending
- 1998-12-14 AP APAP/P/2000/001831A patent/AP1365A/en active
- 1998-12-14 UA UA2000063485A patent/UA72198C2/uk unknown
- 1998-12-14 EA EA200000654A patent/EA004260B1/ru not_active IP Right Cessation
- 1998-12-14 BR BR9813600-3A patent/BR9813600A/pt not_active Application Discontinuation
- 1998-12-15 UY UY25304A patent/UY25304A1/es unknown
- 1998-12-15 ZA ZA9811506A patent/ZA9811506B/xx unknown
- 1998-12-15 MY MYPI98005674A patent/MY135612A/en unknown
- 1998-12-15 EG EG155698A patent/EG22337A/xx active
- 1998-12-15 DZ DZ980291A patent/DZ2681A1/xx active
- 1998-12-15 AR ARP980106370A patent/AR017214A1/es unknown
- 1998-12-15 UY UY25308A patent/UY25308A1/es not_active IP Right Cessation
- 1998-12-16 TR TR1998/02625A patent/TR199802625A3/tr unknown
- 1998-12-16 CO CO98074834A patent/CO4980880A1/es unknown
- 1998-12-16 IN IN3772DE1998 patent/IN192487B/en unknown
- 1998-12-16 PE PE1998001233A patent/PE20000058A1/es not_active Application Discontinuation
- 1998-12-16 TW TW087121121A patent/TW509690B/zh not_active IP Right Cessation
-
1999
- 1999-02-27 SA SA99191115A patent/SA99191115B1/ar unknown
-
2000
- 2000-06-15 NO NO20003069A patent/NO317254B1/no not_active IP Right Cessation
- 2000-06-16 HR HR20000408A patent/HRP20000408B1/xx not_active IP Right Cessation
- 2000-07-13 BG BG104603A patent/BG64988B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4980880A1 (es) | Hidrato novedoso n-(2-piridil)amino)etoxi]etoxi]bencil]tiazolidin-2-4-diona | |
| CO4990943A1 (es) | Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2-4-diona | |
| CO5170424A1 (es) | Nuevosa compuestos antidiabeticos | |
| KR0179054B1 (en) | Heterocyclic-cyclic amine derivatives | |
| AR023561A1 (es) | Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento | |
| AP1441A (en) | Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt. | |
| CO5170419A1 (es) | Nuevo compuesto antidiabetico con base en sales del acido maleico | |
| CO5170420A1 (es) | Nuevos farmacos hidrocloruro | |
| ECSP982780A (es) | Nuevo producto farmaceutico proceso para su preparacion y su uso en medicina | |
| ECSP003438A (es) | Nuevos compuestos | |
| ECSP003436A (es) | Nuevos compuestos | |
| ECSP003434A (es) | Nuevos compuestos | |
| ECSP982779A (es) | Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina | |
| AR017867A1 (es) | Un hidrato de la sal del acido maleico de 5-4-2-(n-metil-n(2-piridil)amino)etoxi bencil tiazolidin-2,4-diona, un proceso para su preparacion, una composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento. |